Randomly divide 70 cases of cold urticaria patients into 2 groups and make observation and comparison.
将70例寒冷性荨麻疹患者，随机分2组进行对比观察。
Objective To evaluate the serum histamine-releasing activity of patients with primary acquired cold urticaria (PACU).
目的探讨原发性获得性寒冷性荨麻疹的组胺释放活性。
Conclusion: the results suggest that mizolastine may be effective and safe in the treatment of primary acquired cold urticaria.
结论：咪唑斯汀治疗原发性获得性寒冷性荨麻疹安全、有效。
Backgrand and Aims PACU is a specific type of urticaria which characterized by the rapid onset of pruritus, erythema, and swelling after a cold stimulus.
背景与目的：PACU是由于人体受寒冷刺激后迅速出现红斑、风团伴瘙痒等表现的一类特殊类型的荨麻疹。
She suffers from recurrent cold and urticaria.
体质较弱，经常感冒和皮肤风团。
She suffers from recurrent cold and urticaria.
体质较弱，经常感冒和皮肤风团。
应用推荐